CA2371500A1 - Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol - Google Patents

Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol Download PDF

Info

Publication number
CA2371500A1
CA2371500A1 CA002371500A CA2371500A CA2371500A1 CA 2371500 A1 CA2371500 A1 CA 2371500A1 CA 002371500 A CA002371500 A CA 002371500A CA 2371500 A CA2371500 A CA 2371500A CA 2371500 A1 CA2371500 A1 CA 2371500A1
Authority
CA
Canada
Prior art keywords
sequence
seq
nucleic acid
sequence seq
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002371500A
Other languages
English (en)
French (fr)
Inventor
Patrice Denefle
Marie-Francoise Rosier-Montus
Isabelle Arnould-Reguigne
Catherine Prades
Christian Clepet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9906587A external-priority patent/FR2794131B1/fr
Application filed by Individual filed Critical Individual
Publication of CA2371500A1 publication Critical patent/CA2371500A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002371500A 1999-05-25 2000-05-25 Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol Abandoned CA2371500A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9906587A FR2794131B1 (fr) 1999-05-25 1999-05-25 Produits d'expression de genes impliques dans des affections associees au metabolisme du cholesterol
FR99/06587 1999-05-25
US13945099P 1999-06-16 1999-06-16
US60/139,450 1999-06-16
PCT/FR2000/001426 WO2000071710A2 (fr) 1999-05-25 2000-05-25 Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol

Publications (1)

Publication Number Publication Date
CA2371500A1 true CA2371500A1 (fr) 2000-11-30

Family

ID=26234967

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002371500A Abandoned CA2371500A1 (fr) 1999-05-25 2000-05-25 Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol

Country Status (11)

Country Link
EP (1) EP1183350A2 (hu)
JP (1) JP2003518918A (hu)
KR (1) KR20020033627A (hu)
AU (1) AU4931800A (hu)
BR (1) BR0010916A (hu)
CA (1) CA2371500A1 (hu)
HU (1) HUP0203164A2 (hu)
IL (1) IL145835A0 (hu)
MX (1) MXPA01011882A (hu)
NO (1) NO20015729L (hu)
WO (1) WO2000071710A2 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055318A2 (en) 1999-03-15 2000-09-21 University Of British Columbia Abc1 polypeptide and methods and reagents for modulating cholesterol levels
WO2002010388A2 (en) * 2000-08-01 2002-02-07 Amgen Inc. C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
AT413701B (de) * 2001-11-06 2006-05-15 Bmt Medizinische Forschung Und Strukturelle und funktionelle charakterisierung von cdw92
WO2008081942A1 (ja) 2007-01-05 2008-07-10 The University Of Tokyo 抗prg-3抗体を用いる癌の診断および治療
CN102112492B (zh) 2007-11-14 2015-02-25 中外制药株式会社 使用抗gpr49抗体的癌症的诊断和治疗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020165A2 (en) * 1996-11-06 1998-05-14 Whitehead Institute For Biomedical Research Biallelic markers

Also Published As

Publication number Publication date
WO2000071710A3 (fr) 2001-05-17
NO20015729D0 (no) 2001-11-23
MXPA01011882A (es) 2002-05-06
NO20015729L (no) 2002-01-22
KR20020033627A (ko) 2002-05-07
HUP0203164A2 (hu) 2002-12-28
EP1183350A2 (fr) 2002-03-06
WO2000071710A2 (fr) 2000-11-30
IL145835A0 (en) 2002-07-25
BR0010916A (pt) 2002-02-19
JP2003518918A (ja) 2003-06-17
AU4931800A (en) 2000-12-12

Similar Documents

Publication Publication Date Title
KR102643936B1 (ko) 병태 및 질환 치료용 안티센스 올리고머
KR101778036B1 (ko) 전립선암 마커로서의 포스포디에스테라제 4ｄ7
KR102110469B1 (ko) 악성의 호르몬 민감성 전립선 암에 대한 마커로서의 포스포디에스테라제 4ｄ7
WO2001012659A2 (en) Human dna sequences
WO1998045436A2 (en) SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
WO1995014772A1 (fr) Signature genique
WO1998045437A2 (en) SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
CA3050151A1 (en) Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof
EP0973898A2 (en) SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
US20040248256A1 (en) Secreted proteins and polynucleotides encoding them
KR101621273B1 (ko) 카텝신 ｃ의 용도
KR20220113743A (ko) 병태 및 질환의 치료를 위한 안티센스 올리고머
CN101151371B (zh) 治疗中的逆转录转座子抑制
JP2003156489A (ja) 痛みに関連する分子の同定及び使用
JP2001245666A (ja) 新規ポリペプチド
KR20220025806A (ko) 핵산의 무작위 구성 표적화 통합
US20030022217A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
CA2371500A1 (fr) Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol
CA2474759A1 (en) Gene for peripheral arterial occlusive disease
US20020192678A1 (en) Genes expressed in senescence
TW202227102A (zh) 治療脂肪肝病之方法
KR102477906B1 (ko) 유도만능 줄기세포 분화 특이적 lncRNA, 및 이의 용도
KR20120106721A (ko) 신경발생 및 이의 조절에 관련된 유전자, 방법, 그리고 조성물
KR100998272B1 (ko) 단백질 지령부위내 단반복 염기서열을 갖는 신규 유전자
US20040238597A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof

Legal Events

Date Code Title Description
FZDE Discontinued